Table 4.
Subgroup analysis excluding participants with SBP ≥180 mm Hg or DBP ≥110 mm Hg at initial clinic visit
| Outcome | PPCPM(n = 179) | Usual care(n = 74) | P value |
|---|---|---|---|
| Baseline SBP, mean (SD), mm Hg | 149.8 (12.2) | 152.6 (10.8) | .09 |
| Baseline DBP, mean (SD), mm Hg | 95.0 (8.2) | 90.7 (9.2) | .0008 |
| No. of days to goal BP, median (95% CI/IQR) | 36 (30–42/15–90) | 270 (182–322/98–357) | <.001 |
| No. of visits to goal BP, mean (SD) | 3.1 (1.4) | 3.0 (1.4) | .45 |
| No. (%) at BP goal at 12‐mo follow‐up | 212 (82) | 56 (47) | <.0001 |
P values based on nonparametric Wilcoxon‐Mann‐Whitney test or time‐to‐event analysis–based long‐rank test.
Data sources: VCU Health System and Center for Healthy Hearts.
Abbreviations: BP, blood pressure; CI, confidence interval; DBP, diastolic blood pressure; IQR, interquartile range; PPCPM, pharmacist‐physician collaborative practice model; SBP, systolic blood pressure; SD, standard deviation.